Nucleolin and ErbB2 inhibition reduces tumorigenicity of ErbB2-positive breast cancerEya Wolfson, Ronit Pinkas‐Kramarski|Cell Death and Disease|2018Cited by 43
Nucleolin-binding by ErbB2 enhances tumorigenicity of ErbB2-positive breast cancerEya Wolfson, Ronit Pinkas‐Kramarski|Oncotarget|2016Cited by 38